Period Prevalence of Advanced Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

AACE Endocrinology and Diabetes · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles